Full-Time

Supervisor

Production Operations

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Springfield, MO, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • High School Diploma
  • 5 years of relative experience in a Production facility
  • Demonstrated leadership capabilities
  • Ability to work a 12 hour shift and cover shifts when needed due to shift vacancies
  • The position requires the management of hazardous waste, which may include making waste determinations, profiling waste with TSDF, labeling hazardous waste containers, container management, and release cleanup/emergency response
Responsibilities
  • Assume the role of Incident Commander during any type of emergency situation and promptly notify proper authorities
  • Conduct performance evaluations for assigned subordinates and provide feedback
  • Provide training for Chemical Operators on Good Documentation Practices related to GMP documents, equipment operation, change control and Process Safety Management information; continually evaluate training programs
  • Ensure operators are trained on changes in procedures and/or equipment and aware of changes
  • Ensure compliance with safety rules, procedures, batch records and work instructions; reinforce expectations for strict compliance
  • Troubleshoot and resolve process and equipment problems; coordinate with maintenance for timely resolution
  • Monitor plant conditions and operator actions to ensure safe operation
  • Be proficient with SAP for work order entry, raw material ordering, scheduling production runs, printing batch sheets
  • Investigate and document root cause of any out of specification batches, safety incidents, process or equipment failure
  • Review production batch sheets daily for accuracy; retrain operators as needed for error-free batch sheets
  • Communicate with other departments to resolve operational issues; maintain communications with Production Managers; provide accurate daily production report and updated projection
  • Issue hot work permits and vessel entry permits as required
  • Initiate, review, and complete Change Control documentation to maintain cGMP and OSHA compliance at the plant site
Desired Qualifications
  • FDA, EPA, and OSHA regulated chemicals manufacturing highly preferred
  • Knowledge, skills and abilities: Ability to work a 12 hour shift and cover shifts when needed due to shift vacancies
  • Good written and verbal communication skills and team oriented management skills
  • Ability to properly prioritize simultaneous events by planning ahead and maximizing efficiency of resources
  • Proficiency in MS Outlook, Excel, Power Point
  • Familiarity with SAP, Factory Talk/Process Control Systems, AIMS, and other software to assist in day-to-day activities

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$1.1B

Headquarters

Albany, New York

Founded

1991

Simplify Jobs

Simplify's Take

What believers are saying

  • Biologics segment expansion under Steve Lavezoli accelerates high-margin pharmaceutical outsourcing revenue growth.
  • Carterra partnership positions Curia to capture Pacific Northwest biotech demand in antibody discovery services.
  • Gerald Auer's CFO appointment signals M&A activity and potential strategic initiatives enhancing shareholder value.

What critics are saying

  • Pace Life Sciences acquisition of New Jersey lab erodes Curia's analytical testing capacity and revenue.
  • Larger CDMOs like Lonza and Catalent undercut Curia on biologics capacity, stealing biotech contracts.
  • FDA scrutiny on srRNA manufacturing defects from Replicate Bioscience Phase 1 triggers potential client exodus.

What makes Curia unique

  • Pioneer in self-replicating RNA manufacturing, demonstrated through Replicate Bioscience Phase 1 clinical trial support.
  • Integrated enzymatic doggybone DNA technology via Touchlight collaboration expands mRNA manufacturing competitive advantages.
  • End-to-end CDMO services from discovery through cGMP manufacturing differentiate Curia from specialized competitors.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Curia who can refer or advise you

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Carlyle Group
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb.com
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

PPI News Agency
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.